ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
10,600
Employees10,600
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
10,600
Employees10,600

RMD Key Statistics

Market cap
36.80B
Market cap36.80B
Price-Earnings ratio
24.96
Price-Earnings ratio24.96
Dividend yield
0.89%
Dividend yield0.89%
Average volume
1.46M
Average volume1.46M
High today
$254.21
High today$254.21
Low today
$243.35
Low today$243.35
Open price
$246.61
Open price$246.61
Volume
971.00K
Volume971.00K
52 Week high
$293.81
52 Week high$293.81
52 Week low
$199.92
52 Week low$199.92

Stock Snapshot

With a market cap of 36.8B, ResMed(RMD) trades at $252.55. The stock has a price-to-earnings ratio of 24.96 and currently yields dividends of 89.5%.

During the trading session on 2026-02-16, ResMed(RMD) shares reached a daily high of $254.21 and a low of $243.35. At a current price of $252.55, the stock is +3.8% higher than the low and still -0.7% under the high.

Trading volume for ResMed(RMD) stock has reached 971K, versus its average volume of 1.46M.

The stock's 52-week range extends from a low of $199.92 to a high of $293.81.

The stock's 52-week range extends from a low of $199.92 to a high of $293.81.

RMD News

Simply Wall St 14h
Is ResMed’s Hardware-Led Margin Strength Quietly Redefining Its Software-Driven Narrative?

In the past few days, ResMed reported largely positive fiscal second-quarter 2026 results, with strength in its Masks & Accessories and Devices segments offsett...

Is ResMed’s Hardware-Led Margin Strength Quietly Redefining Its Software-Driven Narrative?
TipRanks 4d
ResMed Tests Smart CPAP Pressure Tool in New Sleep Apnea Trial

Resmed Inc (RMD) announced an update on their ongoing clinical study. ResMed’s new study, “Trial of a New Software Tool for Personalized Minimum and Maximum Pr...

Simply Wall St 5d
Assessing ResMed Valuation After Recent Share Price Swings And Growth Expectations

Advertisement ResMed stock snapshot after recent moves ResMed (RMD) has drawn attention after recent share price swings, with the stock closing at US$259.62....

Assessing ResMed Valuation After Recent Share Price Swings And Growth Expectations

Analyst ratings

72%

of 29 ratings
Buy
72.4%
Hold
24.1%
Sell
3.4%

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.